Related Experiment Videos
What your patients don't tell you
American Family Physician
|May 23, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).
BJOG : an international journal of obstetrics and gynaecology·2021
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Expert opinion on pharmacotherapy·2018
The Process of Family Reconstruction after DNA Testing for Huntington Disease.
Journal of genetic counseling·2015
Thyroid ophthalmopathy.
Minerva endocrinologica·2005
Primary antiphospholipid syndrome: functional outcome after 10 years.
The Journal of rheumatology·2000
Nausea and Vomiting During Pregnancy.
American family physician·2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.
American family physician·2026
Type 2 Diabetes: Outpatient Insulin Management.
American family physician·2026
Recurrent UTI in Women: Diagnosis and Management.
American family physician·2026
Gambling Disorder: Diagnosis and Treatment.
American family physician·2026
Pacemaker Therapy: Indications and Recommendations.
American family physician·2026
Beyond the treatment episode: Closing gaps across the continuum of care.
The Medical journal of Malaysia·2026
Hospital Responses to New Disproportionate Share Payment Rules.
Health services research·2026
Postimplementation evaluation of cytopathology amendment reports after adoption of a new laboratory information system: identifying diagnostic, reporting, and workflow challenges.
Journal of the American Society of Cytopathology·2026
Evaluating the Accessibility of Online Resources Regarding Biceps Tenodesis.
The Journal of the American Academy of Orthopaedic Surgeons·2026
Evaluating Global Disparities in the Availability of Prostate Cancer Clinical Trials.
JCO global oncology·2026